Login / Signup

Reporting of health equity considerations in cluster and individually randomized trials.

Jennifer PetkovicJanet JullManosila YoganathanOmar DewidarSarah BairdJeremy M GrimshawKjell Arne JohanssonElizabeth KristjanssonJessie McGowanDavid MoherMark PetticrewBjarne RobberstadBeverley SheaPeter TugwellJimmy VolminkGeorge A WellsMargaret WhiteheadLuis Gabriel CuervoHoward WhiteMonica TaljaardVivian Welch
Published in: Trials (2020)
In this set of trials, selected for their relevance to health equity, data that were disaggregated for socially disadvantaged populations were rarely reported. We found that even when the data are available, opportunities to analyze health-equity considerations are frequently missed. The recently published equity extension of the Consolidated Reporting Standards for Randomized Trials (CONSORT-Equity) may help improve delineation of hypotheses related to socially disadvantaged populations, and transparency and completeness of reporting of health-equity considerations in RCTs. This study can serve as a baseline assessment of the reporting of equity considerations.
Keyphrases
  • public health
  • healthcare
  • global health
  • mental health
  • adverse drug
  • health information
  • electronic health record
  • health promotion
  • randomized controlled trial
  • human health
  • big data
  • systematic review